Compare BHVN & KDK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHVN | KDK |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2022 | N/A |
| Metric | BHVN | KDK |
|---|---|---|
| Price | $8.96 | $7.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $28.85 | $15.38 |
| AVG Volume (30 Days) | ★ 1.9M | 330.4K |
| Earning Date | 03-02-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $213.48 |
| Revenue Next Year | N/A | $513.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.48 | $5.43 |
| 52 Week High | $31.18 | $11.35 |
| Indicator | BHVN | KDK |
|---|---|---|
| Relative Strength Index (RSI) | 30.23 | 33.07 |
| Support Level | $8.40 | $7.00 |
| Resistance Level | $15.66 | $9.45 |
| Average True Range (ATR) | 0.65 | 0.48 |
| MACD | -0.14 | -0.09 |
| Stochastic Oscillator | 4.26 | 3.79 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Kodiak AI Inc is engaged in the commercial trucking industry and the public sector, based on AI-powered autonomous vehicle technology.